NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · IEX Real-Time Price · USD
7.23
-0.09 (-1.23%)
Jul 2, 2024, 4:00 PM EDT - Market closed
NeuroPace Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for NeuroPace stock have an average target of 17, with a low estimate of 12 and a high estimate of 22. The average target predicts an increase of 135.13% from the current stock price of 7.23.
Analyst Consensus: Buy
* Price targets were last updated on May 9, 2024.
Analyst Ratings
The average analyst rating for NeuroPace stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $18 | Buy | Reiterates | $18 | +148.96% | May 9, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $16 → $20 | Hold → Buy | Upgrades | $16 → $20 | +176.63% | Mar 14, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $9 → $17 | Buy | Maintains | $9 → $17 | +135.13% | Mar 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $16 → $18 | Buy | Maintains | $16 → $18 | +148.96% | Mar 6, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $9 → $13 | Hold | Maintains | $9 → $13 | +79.81% | Mar 6, 2024 |
Financial Forecast
Revenue This Year
77.42M
from 65.42M
Increased by 18.34%
Revenue Next Year
91.08M
from 77.42M
Increased by 17.65%
EPS This Year
-1.18
from -1.27
EPS Next Year
-1.05
from -1.18
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 80.9M | 97.7M | 131.0M | 159.8M | 229.3M |
| Avg | 77.4M | 91.1M | 111.1M | 155.3M | 211.1M |
| Low | 72.9M | 82.3M | 92.1M | 149.2M | 191.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 23.6% | 26.1% | 43.9% | 43.9% | 47.7% |
| Avg | 18.3% | 17.6% | 21.9% | 39.8% | 36.0% |
| Low | 11.5% | 6.3% | 1.2% | 34.3% | 23.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.14 | -0.50 | 0.19 | -0.29 | 0.28 |
| Avg | -1.18 | -1.05 | -0.66 | -0.29 | 0.28 |
| Low | -1.22 | -1.23 | -0.89 | -0.27 | 0.26 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.